Atlas Trials

The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy

Clinical trial NCT04591431 · UNKNOWN

Trial details

NCT number
NCT04591431
Sponsor
Fondazione per la Medicina Personalizzata
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerGastrointestinal CancerNon Small Cell Lung CancerOther Cancer
Start date
2020-10-07
Primary completion
2024-12-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.